These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1620 related articles for article (PubMed ID: 33950718)
1. Expanding Mail-Based Distribution of Drug-Related Harm Reduction Supplies Amid COVID-19 and Beyond. Barnett BS; Wakeman SE; Davis CS; Favaro J; Rich JD Am J Public Health; 2021 Jun; 111(6):1013-1017. PubMed ID: 33950718 [No Abstract] [Full Text] [Related]
2. NEXT Harm Reduction: An Online, Mail-Based Naloxone Distribution and Harm-Reduction Program. Yang C; Favaro J; Meacham MC Am J Public Health; 2021 Apr; 111(4):667-671. PubMed ID: 33600254 [TBL] [Abstract][Full Text] [Related]
3. How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder? Salisbury-Afshar E; Livingston CJ; Bluthenthal RN AMA J Ethics; 2024 Jul; 26(7):E562-571. PubMed ID: 38958425 [TBL] [Abstract][Full Text] [Related]
4. Survey of Southern Wisconsin Needle Exchange Clients Regarding Opioid Overdose and Naloxone Use. Baltes A; Devo B; Kaiser M; Birstler J; Brown RT WMJ; 2019 Jul; 118(2):84-87. PubMed ID: 31532934 [TBL] [Abstract][Full Text] [Related]
5. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Doe-Simkins M; Walley AY; Epstein A; Moyer P Am J Public Health; 2009 May; 99(5):788-91. PubMed ID: 19363214 [TBL] [Abstract][Full Text] [Related]
6. Harm Reduction Strategies for the Opiod Crisis. Castillo T N C Med J; 2018; 79(3):192-194. PubMed ID: 29735629 [TBL] [Abstract][Full Text] [Related]
8. Harm Reduction: Front Line Public Health. Stancliff S; Phillips BW; Maghsoudi N; Joseph H J Addict Dis; 2015; 34(2-3):206-19. PubMed ID: 26080038 [TBL] [Abstract][Full Text] [Related]
9. Identifying gaps in the implementation of naloxone programs for laypersons in the United States. Lambdin BH; Zibbell J; Wheeler E; Kral AH Int J Drug Policy; 2018 Feb; 52():52-55. PubMed ID: 29232604 [No Abstract] [Full Text] [Related]
10. The naloxone option. Prabhu A; Abaid B; Khaleel MS; Naik S; Lippman M; Lippman S J Fam Pract; 2018 May; 67(5):288;290;292. PubMed ID: 29726853 [TBL] [Abstract][Full Text] [Related]
13. Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada. Strike C; Watson TM Int J Drug Policy; 2019 Sep; 71():178-182. PubMed ID: 30975595 [TBL] [Abstract][Full Text] [Related]
14. Expanding the accessibility of harm reduction services in the United States: Measuring the impact of an automated harm reduction dispensing machine. Arendt D J Am Pharm Assoc (2003); 2023; 63(1):309-316. PubMed ID: 36549931 [TBL] [Abstract][Full Text] [Related]
15. Got Narcan? Gould KA Dimens Crit Care Nurs; 2019; 38(1):1-4. PubMed ID: 30499785 [No Abstract] [Full Text] [Related]
19. Harm Reduction, By Mail: the Next Step in Promoting the Health of People Who Use Drugs. Hayes BT; Favaro J; Davis CS; Gonsalves GS; Beletsky L; Vlahov D; Heimer R; Fox AD J Urban Health; 2021 Aug; 98(4):532-537. PubMed ID: 33710493 [No Abstract] [Full Text] [Related]
20. Take home naloxone for opiate addicts. Big conclusions are drawn from little evidence. Mountain D BMJ; 2001 Oct; 323(7318):934; author reply 935. PubMed ID: 11693143 [No Abstract] [Full Text] [Related] [Next] [New Search]